BAJAJ BROKING
Dr Reddy’s Laboratories inaugurated a 70,000 sq ft biologics facility in Genome Valley, Hyderabad, through its subsidiary Aurigene, emphasising process and analytical development for antibodies and recombinant proteins. It aligns with Dr Reddy’s commitment to advancing biologics research and development.
Dr Reddy’s Laboratories revealed the inauguration of a new biologics facility spanning 70,000 sq ft in Genome Valley, Hyderabad, operated by its subsidiary, Aurigene Pharmaceutical Services Limited. The facility aims to address process and analytical development and small-scale manufacturing requirements for antibodies and other recombinant proteins.
Explore: Dr. Reddy's Laboratories
While the process and analytical development laboratories are already operational, the manufacturing capacity is slated for completion later in 2024, as per a regulatory filing by Dr Reddy’s Labs.
This addition complements the company’s existing infrastructure, concentrating on various recombinant proteins such as monoclonal antibodies (mAbs), bi- and multi-specifics, and immune-fusion molecules.
Aurigene's service spectrum now covers discovery to large-scale commercial manufacturing, facilitated by three nearby campuses. This alignment ensures seamless progression from conceptualization to commercialization, catering to diverse customer needs.
Aurigene CEO Akhil Ravi expressed confidence that the new facility's capabilities will enhance global customer service and support innovative medicine development.
Dr Roger Lias, Aurigene's global commercial head for biologics, emphasised the rarity of global CDMOs providing end-to-end services, highlighting Aurigene's strengthened capabilities and technical prowess.
The industry also witnessed Aurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, securing a contract manufacturing agreement with Merck Sharpe & Dohme Singapore Trading Pte Ltd for biological production. Additionally, researchers at IISc introduced a safer protein production method using MSG, replacing hazardous methanol.
This comprehensive expansion underscores Dr Reddy’s commitment to strengthening its biologics capabilities and serving the evolving needs of the pharmaceutical industry.
Additional Read: Dr. Reddy's Laboratories Ltd.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Godrej Properties Acquires 53-Acre Land in Kolkata for ₹500 Crore
21 Nov, 2024 | 2 Min. read
GNFC Partners with INEOS to Build 600kt Acetic Acid Plant in Gujarat
21 Nov, 2024 | 2 Min. read
Adani Infra Launches Open Offer to Buy 26% Stake in PSP Projects
21 Nov, 2024 | 2 Min. read
UPL’s Advanta Secures $350M Investment from Alpha Wave Global
21 Nov, 2024 | 2 Min. read
Commodities Market Today | Crude Oil Drops, Gold Rises, Silver Falls in Market Moves
21 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Signals Weak Opening, Indian Markets May Consolidate
21 Nov, 2024 | 4 Min. read
Gold Rate Today | Gold Gains 0.9% to $2,653.50, Silver Drops 1%
21 Nov, 2024 | 2 Min. read
Know C2C Advanced Systems IPO Review, Objective & Applying Process
21 Nov, 2024 | 1 Min. read
Explore the List of Top Education Stocks in India
21 Nov, 2024 | 8 Min. read
What are Reverse Stock Splits: Meaning & Example
21 Nov, 2024 | 7 Min. read
How to Apply Under Shareholders' Quota in NTPC Green Energy IPO?
21 Nov, 2024 | 1 Min. read
What is Personal Finance? Meaning & Importance
21 Nov, 2024 | 4 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading